Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Gastrointestinal Stromal Tumor (GIST)”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Testing effectiveness (Phase 2)Ended earlyNCT01316263
What this trial is testing

Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Eli Lilly and Company 21
Testing effectiveness (Phase 2)UnknownNCT02982486
What this trial is testing

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Who this might be right for
Soft Tissue SarcomaBone SarcomaChondrosarcoma+5 more
Assaf-Harofeh Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT02401815
What this trial is testing

CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc. 51
Large-scale testing (Phase 3)Ended earlyNCT00009906
What this trial is testing

Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 748
Early research (Phase 1)WithdrawnNCT02268435
What this trial is testing

Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center
Large-scale testing (Phase 3)UnknownNCT00685828
What this trial is testing

Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC 946
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT01110668
What this trial is testing

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor
Novartis Pharmaceuticals 2
Testing effectiveness (Phase 2)UnknownNCT04138381
What this trial is testing

Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)

Who this might be right for
Maximum Tolerated DoseGISTMetastatic Adult Soft Tissue Sarcoma+2 more
Grupo Espanol de Investigacion en Sarcomas 30
Large-scale testing (Phase 3)Study completedNCT01694277
What this trial is testing

Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
AB Science 258
Testing effectiveness (Phase 2)Study completedNCT01323400
What this trial is testing

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
GIST
Centre Leon Berard 81
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Not applicableApproved For MarketingNCT03862885
What this trial is testing

Early Access Program (EAP) for Avapritinib in Patients With Locally Advanced Unresectable or Metastatic GIST

Who this might be right for
GIST
Blueprint Medicines Corporation
Testing effectiveness (Phase 2)Study completedNCT02638766
What this trial is testing

Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST

Who this might be right for
Gastrointestinal Stromal Tumors
Grupo Espanol de Investigacion en Sarcomas 15
Testing effectiveness (Phase 2)Study completedNCT03609424
What this trial is testing

PDR001 Plus Imatinib for Metastatic or Unresectable GIST

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 39
Large-scale testing (Phase 3)Study completedNCT00785785
What this trial is testing

Nilotinib Versus Imatinib in GIST Patients

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Novartis Pharmaceuticals 644
Not applicableUnknownNCT04825470
What this trial is testing

Liver Transplantation for Unresectable GIST Liver Metastases

Who this might be right for
Liver DiseasesLiver CancerLiver Metastases+25 more
Hospital Universitario Virgen de la Arrixaca 50
Large-scale testing (Phase 3)Ended earlyNCT00688766
What this trial is testing

Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib

Who this might be right for
Gastrointestinal Stromal Tumors
Infinity Pharmaceuticals, Inc. 47
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Large-scale testing (Phase 3)Looking for participantsNCT07218926
What this trial is testing

IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

Who this might be right for
Gastrointestinal Neoplasms
GlaxoSmithKline 450
Next Page